Is JNJ halal?
Johnson & Johnson
Johnson & Johnson (JNJ) is included in the current HalalSignalz stock passlist as of May 7, 2026. This is an educational passlist snapshot, not a fatwa, personal financial advice, or a permanent status guarantee.
On HalalSignalz halal stock passlist
Screen: AAOIFI. Category: Healthcare - Big Pharma.
What does Johnson & Johnson do?
Johnson & Johnson sells medical technology, surgical products, orthopedics, vision care, and pharmaceutical treatments across global healthcare markets.
Halal strength
Positive
Technical
Neutral
Quarterly / fundamental
Neutral
Sentiment
Neutral
Ratings are conservative HalalSignalz snapshot labels from the checked-in passlist. Technical and sentiment labels default to Neutral unless the current snapshot has a stronger reason to flag Watch, Positive, or Weak.
Chart and Market Context
Review live candles, volume, and trend separately from the halal passlist verdict. A ticker can be on the passlist and still be poorly timed, overextended, illiquid, or too volatile for a given portfolio.
Company Fundamentals Snapshot
FMP fundamentals add business context for Johnson & Johnson; the HalalSignalz verdict above remains the main value of this page. Use these figures to sanity-check size, profitability, and quality before moving to chart timing or a paid signal.
FMP period: 2026 Q1, 2026-03-29.
- Quarterly revenue
- $24.06B
- Gross margin 71.5%.
- Quarterly net income
- $5.24B
- Net margin 21.8%.
- Market cap at data snapshot
- $592.94B
- P/E ratio
- 28.3x
- Diluted EPS 2.14 in the same filing period.
- Free cash flow yield
- 0.2%
- Return on equity
- 6.4%
- Current ratio 1.03.
Passlist Snapshot
- Business screen
- Passlist reviewed
- Healthcare - Big Pharma. Source: FMP checked-in deploy snapshot.
- Debt / market cap
- 3.0%
- $17.50B interest-bearing debt / $592.94B market cap.
- Cash / market cap
- 3.7%
- $22.05B cash and equivalents / $592.94B market cap.
- Reported interest income / revenue
- 0.0%
- $0 reported interest income / $24.06B revenue. Proxy only; this is not a full business-line impermissible revenue audit.
Halal Screening Notes
Healthcare - Big Pharma business activity reviewed as part of the current passlist.
What to Recheck Before Acting
JNJ being present on this passlist only answers the first screening question. These are the next checks before treating Johnson & Johnson as investable for your own portfolio.
- Review the latest 10-Q or 10-K for Johnson & Johnson, especially debt, cash, and interest-income ratios.
- Confirm Johnson & Johnson's business mix still matches the screened category: Healthcare - Big Pharma.
- Check valuation, earnings trend, liquidity, and position size separately from the halal screen.
Related Healthcare - Big Pharma Research
Compare JNJ with nearby passlist names so the halal screen, business activity, and timing context are not reviewed in isolation.
JNJ Halal Screening FAQ
- Is JNJ halal according to HalalSignalz?
- The current HalalSignalz verdict for JNJ is: On HalalSignalz halal stock passlist. This May 7, 2026 stock passlist snapshot uses AAOIFI screening context.
- Does this stock page mean JNJ is a buy?
- No. This page is an educational halal-screening snapshot for Johnson & Johnson; investors still need to review valuation, timing, liquidity, risk size, and their own scholar or advisor guidance.
- What should be checked before acting on JNJ?
- Johnson & Johnson should be rechecked against fresh filings, business changes, market conditions, and any purification requirements before making an investment decision.